Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
Tałałaj
M
M
Department of Internal Medicine, Postgraduate Medical Education Centre, Warsaw Medical School, Poland.
Gradowska
L
L
Marcinowska-Suchowierska
E
E
Durlik
M
M
Gaciong
Z
Z
Lao
M
M
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects*; D002117:Calcitriol / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D002119:Calcium Carbonate / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D011183:Postoperative Complications; D011241:Prednisone / Q000009:adverse effects*
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D010281:Parathyroid Hormone; D010710:Phosphates; D016572:Cyclosporine; D002117:Calcitriol; D002119:Calcium Carbonate; D001379:Azathioprine; D002118:Calcium; D011241:Prednisone